Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7276250 Sustained release formulations of oxymorphone

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 2 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11911512 Encased tamper resistant controlled release dosage forms
0
Edits on 1 Sep, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 1 Sep, 2023
Edits made to:
Article (+390 characters)
Article

Patent abstract

Sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.

Edits on 23 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0727625000
Edits on 18 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 18 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07276250 Sustained release formulations of oxymorphone US Patent 7276250 Sustained release formulations of oxymorphone

Infobox
Patent Number
0727625000
Patent Number
727625000
Edits on 25 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
072762500
Date of Patent
October 2, 2007
0
Patent Application Number
101899320
Date Filed
July 3, 2002
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=072762500
Patent Primary Examiner
‌
Lakshmi S Channavajjala
0
Edits on 28 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
072762500
Date of Patent
October 2, 2007
0
Patent Application Number
101899320
Date Filed
July 3, 2002
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=072762500
Patent Primary Examiner
‌
Lakshmi S Channavajjala
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07276250
Edits on 22 Nov, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 22 Nov, 2021
Edits made to:
Infobox (+7 properties)
‌

 US Patent 07276250 Sustained release formulations of oxymorphone

Infobox
Is a
Patent
Patent
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07276250
Date of patent
October 2, 2007
Patent application number
10189932
Date Filed
July 3, 2002
Patent primary examiner
‌
Lakshmi S Channavajjala

Find more entities like US Patent 7276250 Sustained release formulations of oxymorphone

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.